Cargando…
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
We report the first case of coronavirus disease 2019 (COVID-19) in a multiple myeloma patient successfully treated with tocilizumab. Although tocilizumab was effective in the treatment of COVID-19 in this case, randomized controlled trials are needed.
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160284/ https://www.ncbi.nlm.nih.gov/pubmed/32243501 http://dx.doi.org/10.1182/bloodadvances.2020001907 |